Rhumbline Advisers Purchases 16,677 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA)
Rhumbline Advisers increased its position in Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) by 6.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 282,066 shares of the biopharmaceutical company’s stock after purchasing an additional 16,677 shares during the quarter. Rhumbline […]
Rhumbline Advisers increased its position in Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) by 6.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 282,066 shares of the biopharmaceutical company’s stock after purchasing an additional 16,677 shares during the quarter. Rhumbline […]
